Buphenyl Related Clinical Trials
Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3 [Not yet recruiting]
Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB) [Recruiting]
Phenylbutyrate Therapy for Maple Syrup Urine Disease [Recruiting]
Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder [Recruiting]
Immune Reconstitution in HIV Disease (IREHIV) [Recruiting]
Immune Reconstitution in Tuberculosis Disease [Recruiting]
Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD) [Completed]
Mechanism of Fatty Acid-Induced Impairment of Glucose-Simulated Insulin Secretion - Effect of Buphenyl [Recruiting]
Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy [Recruiting]
Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis) [Active, not recruiting]
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I [Recruiting]
Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III [Recruiting]
Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors [Completed]
Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma [Completed]
Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders [Recruiting]
Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer [Active, not recruiting]
Study of the Efficacy and Safety of HPN-100, Glyceryl Tri-(4-phenylbutyrate), for the Treatment of Adults With Urea Cycle Disorders (Help UCD) [Recruiting]
Phenylbutyrate/Genistein Duotherapy in Delta F508-Homozygous(for Cystic Fibrosis) [Completed]
Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Completed]
5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia [Completed]
Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis) [Recruiting]
Phenylbutyrate in Treating Children With Progressive or Recurrent Cancer of the Central Nervous System [Active, not recruiting]
Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy [Completed]
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-Small Cell Lung Cancer, or Prostate Cancer [Completed]
Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia [Completed]
Fluorouracil, Phenylbutyrate, Indomethacin, and Interferon Gamma in Treating Patients With Advanced Colorectal Cancer [Completed]
Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment [Completed]
Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children 6-17 Years of Age With Urea Cycle Disorders, With a Long-Term Safety Extension [Recruiting]
Phase II Study of Azacitidine and Phenylbutyrate in Patients With Thalassemia Major [Terminated]
Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer [Completed]
Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders [Completed]
Effect of Endoplasmic Reticulum Stress on Metabolic Function [Recruiting]
Study of the Safety of HPN-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD) [Not yet recruiting]
Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs) [Recruiting]
A Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy (HALT-HE) [Recruiting]
A Double-Blind Randomized Crossover Trial to Define the Electrocardiogram Effects of HPN-100 [Recruiting]
|